» Articles » PMID: 34070516

DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer

Abstract

We investigated aberrant DNA methylation (DNAm) changes and the contribution of ageing-associated methylomic drift and age acceleration to early-onset colorectal cancer (EOCRC) carcinogenesis. Genome-wide DNAm profiling using the Infinium HM450K on 97 EOCRC tumour and 54 normal colonic mucosa samples was compared with: (1) intermediate-onset CRC (IOCRC; diagnosed between 50-70 years; 343 tumour and 35 normal); and (2) late-onset CRC (LOCRC; >70 years; 318 tumour and 40 normal). CpGs associated with age-related methylation drift were identified using a public dataset of 231 normal mucosa samples from people without CRC. DNAm-age was estimated using epiTOC2. Common to all three age-of-onset groups, 88,385 (20% of all CpGs) CpGs were differentially methylated between tumour and normal mucosa. We identified 234 differentially methylated genes that were unique to the EOCRC group; 13 of these DMRs/genes were replicated in EOCRC compared with LOCRCs from TCGA. In normal mucosa from people without CRC, we identified 28,154 CpGs that undergo ageing-related DNAm drift, and of those, 65% were aberrantly methylated in EOCRC tumours. Based on the mitotic-based DNAm clock epiTOC2, we identified age acceleration in normal mucosa of people with EOCRC compared with normal mucosa from the IOCRC, LOCRC groups ( = 3.7 × 10) and young people without CRC ( = 5.8 × 10). EOCRC acquires unique DNAm alterations at 234 loci. CpGs associated with ageing-associated drift were widely affected in EOCRC without needing the decades-long accrual of DNAm drift as commonly seen in intermediate- and late-onset CRCs. Accelerated ageing in normal mucosa from people with EOCRC potentially underlies the earlier age of diagnosis in CRC carcinogenesis.

Citing Articles

DNA methylation profiling at base-pair resolution reveals unique epigenetic features of early-onset colorectal cancer in underrepresented populations.

Li J, Riggins K, Yang L, Chen C, Castro P, Alfarkh W Clin Epigenetics. 2025; 17(1):11.

PMID: 39844333 PMC: 11753045. DOI: 10.1186/s13148-025-01817-z.


Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.

Zinkeng A, Taylor F, Cheong S, Song H, Merchant J Cell Mol Gastroenterol Hepatol. 2024; 19(2):101425.

PMID: 39510499 PMC: 11731505. DOI: 10.1016/j.jcmgh.2024.101425.


Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the :c.1528C>T South African Founder Variant.

Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R Biomedicines. 2024; 12(10).

PMID: 39457514 PMC: 11505229. DOI: 10.3390/biomedicines12102201.


Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population.

Luo W, Jiao Y, Lin X, Zhao Y, Wang S, Shen J World J Gastrointest Oncol. 2024; 16(4):1361-1373.

PMID: 38660655 PMC: 11037044. DOI: 10.4251/wjgo.v16.i4.1361.


Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer.

Zhou Y, Chen X, Chen J, Kendrick C, Ramanathan R, Graham R Sci Rep. 2024; 14(1):9368.

PMID: 38654044 PMC: 11039710. DOI: 10.1038/s41598-024-59398-5.


References
1.
Ahuja N, Li Q, Mohan A, Baylin S, Issa J . Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998; 58(23):5489-94. View

2.
Levine M, Lu A, Quach A, Chen B, Assimes T, Bandinelli S . An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018; 10(4):573-591. PMC: 5940111. DOI: 10.18632/aging.101414. View

3.
Peters T, Buckley M, Statham A, Pidsley R, Samaras K, Lord R . De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 2015; 8:6. PMC: 4429355. DOI: 10.1186/1756-8935-8-6. View

4.
Luo Y, Yu M, Grady W . Field cancerization in the colon: a role for aberrant DNA methylation?. Gastroenterol Rep (Oxf). 2014; 2(1):16-20. PMC: 3920999. DOI: 10.1093/gastro/got039. View

5.
Yu M, Hazelton W, Luebeck G, Grady W . Epigenetic Aging: More Than Just a Clock When It Comes to Cancer. Cancer Res. 2019; 80(3):367-374. PMC: 7002254. DOI: 10.1158/0008-5472.CAN-19-0924. View